Can Fite Biopharma Stock Revenue
| CANF Stock | 2.70 0.10 3.85% |
Can Fite Biopharma fundamentals help investors to digest information that contributes to Can Fite's financial success or failures. It also enables traders to predict the movement of Can Stock. The fundamental analysis module provides a way to measure Can Fite's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Can Fite stock.
Can |
Can Fite Biopharma Company Revenue Analysis
Can Fite's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Can Fite Revenue | 853 K |
Most of Can Fite's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Can Fite Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Can Fite Biopharma reported 853 K of revenue. This is 99.99% lower than that of the Biotechnology sector and 99.89% lower than that of the Health Care industry. The revenue for all Israel stocks is 99.99% higher than that of the company.
Can Fite Biopharma is the top company in revenue category among related companies. Market size based on revenue of Health Care industry is currently estimated at about 6.85 Million. Can Fite retains roughly 853,000 in revenue claiming about 12% of equities under Health Care industry.Can Fundamentals
| Return On Equity | -1.34 | |||
| Return On Asset | -0.5 | |||
| Operating Margin | (13.51) % | |||
| Current Valuation | 35.67 M | |||
| Shares Outstanding | 1.01 B | |||
| Price To Earning | (337.46) X | |||
| Price To Book | 2.84 X | |||
| Price To Sales | 85.87 X | |||
| Revenue | 853 K | |||
| Gross Profit | 853 K | |||
| EBITDA | (12.83 M) | |||
| Net Income | (12.62 M) | |||
| Cash And Equivalents | 3.21 M | |||
| Cash Per Share | 0.07 X | |||
| Current Ratio | 2.75 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (9.86 M) | |||
| Earnings Per Share | (0.03) X | |||
| Target Price | 6.0 | |||
| Beta | 0.79 | |||
| Market Capitalization | 41.28 M | |||
| Total Asset | 20.25 M | |||
| Net Asset | 20.25 M |
About Can Fite Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Can Fite Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Can Fite using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Can Fite Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Can Fite in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Can Fite's short interest history, or implied volatility extrapolated from Can Fite options trading.
Pair Trading with Can Fite
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Can Fite position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Can Fite will appreciate offsetting losses from the drop in the long position's value.Moving together with Can Stock
| 0.75 | DCI | Direct Capital Inves | PairCorr |
| 0.66 | SAFE | Safe T Group | PairCorr |
Moving against Can Stock
| 0.5 | GIVO-L | GIVOT OLAM OIL | PairCorr |
| 0.47 | FVT | Ai Conversation Systems | PairCorr |
The ability to find closely correlated positions to Can Fite could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Can Fite when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Can Fite - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Can Fite Biopharma to buy it.
The correlation of Can Fite is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Can Fite moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Can Fite Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Can Fite can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Can Fite Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Can Stock analysis
When running Can Fite's price analysis, check to measure Can Fite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Can Fite is operating at the current time. Most of Can Fite's value examination focuses on studying past and present price action to predict the probability of Can Fite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Can Fite's price. Additionally, you may evaluate how the addition of Can Fite to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |